OP0043 Twenty-Four Weeks of Treatment with a Novel...

Annals of the Rheumatic Diseases 2013 / 06 Vol. 72; Iss. Suppl 3

OP0043 Twenty-Four Weeks of Treatment with a Novel Anti-IL-6 Receptor Nanobody(R) (ALX-0061) Resulted in 84% ACR20 Improvement and 58% DAS28 Remission in a Phase I/Ii Study in RA

Holz, J.- B., Sargentini-Maier, L., De Bruyn, S., Gachalyi, B., Udvaros, I., Rojkovich, B., Bruk, S., Sramek, P., Korkosz, M., Krause, K., Schoen, P., D'Artois, J., Verschueren, K., Willems, W., De Sw
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
72
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2013-eular.248
Date:
June, 2013
File:
PDF, 358 KB
english, 2013
Conversion to is in progress
Conversion to is failed